Turnstone Biologics Corp. (Stock Symbol: TSBX)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $8 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Turnstone Biologics Corp. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Turnstone Biologics Corp. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Turnstone Biologics Corp. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Turnstone Biologics Corp. interactive price chart and technical analysis...
Deep dive into Turnstone Biologics Corp.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Turnstone Biologics Corp. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Turnstone Biologics Corp.: With a P/E ratio of -0.14, the market sees the stock as potentially undervalued.
P/E Ratio-0.14x
P/B Ratio0.56x
Market Cap$8M
EPS$-2.04
Book Value/Share$0.64
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Turnstone Biologics Corp. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Turnstone Biologics Corp.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Turnstone Biologics Corp.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Turnstone Biologics Corp.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Turnstone Biologics Corp.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Turnstone Biologics Corp.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Turnstone Biologics Corp. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Turnstone Biologics Corp.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Turnstone Biologics Corp.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Turnstone Biologics Corp.:
Income Statement ($ Millions)
R&D Expense$62M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding23M
Growth Metrics (YoY)
EPS Growth-688.2%
Turnstone Biologics Corp. (TSBX) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Turnstone Biologics Corp. stock analysis.
Loading fundamental data...
Loading Turnstone Biologics Corp. comprehensive fundamental analysis and insider trading data...
--Turnstone Biologics Corp., a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating ...
EMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and Turnstone Biologics Corp. (TSBX) today announced that they have ...
--Turnstone Biologics Corp., a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating ...
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated ...
Turnstone Biologics Corp. (TSBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights PRESS RELEASE GlobeNewswire Mar. 21, 2024, 05:06 PM ...
Turnstone undertakes no obligation to update any forward-looking statement in this press release, except as required by law. Contact Ahmed Aneizi Investor Relations Turnstone Biologics (347) 897-5988 ...
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid ...
Comparative analysis of Turnstone Biologics Corp. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
How accurate are Turnstone Biologics Corp. stock predictions?
Our AI model demonstrates 23% historical accuracy for TSBX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Turnstone Biologics Corp. stock price forecasts?
Is Turnstone Biologics Corp. a good investment in 2025?
Based on our AI analysis, Turnstone Biologics Corp. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Turnstone Biologics Corp. forecasts updated?
Turnstone Biologics Corp. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Turnstone Biologics Corp. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Turnstone Biologics Corp. stock.
